These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28339084)
21. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
22. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation. Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347 [TBL] [Abstract][Full Text] [Related]
23. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704 [TBL] [Abstract][Full Text] [Related]
25. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma. Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084 [TBL] [Abstract][Full Text] [Related]
26. Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Huang P; Qiu J; Li B; Hong J; Lu C; Wang L; Wang J; Hu Y; Jia W; Yuan Y Clin Biochem; 2011 Jun; 44(8-9):582-9. PubMed ID: 21376027 [TBL] [Abstract][Full Text] [Related]
27. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression. Shang R; Pu M; Li Y; Wang D Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073 [TBL] [Abstract][Full Text] [Related]
28. Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression. Sun J; Wang B; Liu Y; Zhang L; Ma A; Yang Z; Ji Y; Liu Y Cancer Lett; 2014 Dec; 355(1):25-33. PubMed ID: 25242357 [TBL] [Abstract][Full Text] [Related]
29. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling. Zong Z; Zou J; Mao R; Ma C; Li N; Wang J; Wang X; Zhou H; Zhang L; Shi Y Front Immunol; 2019; 10():1643. PubMed ID: 31379842 [TBL] [Abstract][Full Text] [Related]
30. Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma. Li WF; Ou Q; Dai H; Liu CA Int J Mol Sci; 2015 Aug; 16(8):19419-32. PubMed ID: 26287185 [TBL] [Abstract][Full Text] [Related]
31. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
32. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes. Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684 [TBL] [Abstract][Full Text] [Related]
33. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955 [TBL] [Abstract][Full Text] [Related]
34. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Xiao X; Lao XM; Chen MM; Liu RX; Wei Y; Ouyang FZ; Chen DP; Zhao XY; Zhao Q; Li XF; Liu CL; Zheng L; Kuang DM Cancer Discov; 2016 May; 6(5):546-59. PubMed ID: 26928313 [TBL] [Abstract][Full Text] [Related]
35. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Xiao H; Jiang N; Zhou B; Liu Q; Du C Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT. Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630 [TBL] [Abstract][Full Text] [Related]
38. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230 [TBL] [Abstract][Full Text] [Related]
39. Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells. Deng Y; Sun J; Zhang LD Genet Mol Res; 2016 Mar; 15(1):15016826. PubMed ID: 26985932 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway. Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]